Status: current, Defined. Date: 30-Apr 2011. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3021011000168115 | Ondansetron (Alphapharm) (ondansetron 4 mg / 2 mL) injection, 5 x 2 mL ampoules (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3021021000168110 | Ondansetron (Alphapharm) 4 mg/2 mL injection, 5 x 2 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ondansetron (Alphapharm) 4 mg/2 mL injection, 5 x 2 mL ampoules | has TPUU | Ondansetron (Alphapharm) 4 mg/2 mL injection, 2 mL ampoule | true | Inferred relationship | Some | 1 | |
| Ondansetron (Alphapharm) 4 mg/2 mL injection, 5 x 2 mL ampoules | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Ondansetron (Alphapharm) 4 mg/2 mL injection, 5 x 2 mL ampoules | Is a | Ondansetron (Alphapharm) 4 mg/2 mL injection, 5 x 2 mL ampoules | true | Inferred relationship | Some | ||
| Ondansetron (Alphapharm) 4 mg/2 mL injection, 5 x 2 mL ampoules | has container type | ampoule | true | Inferred relationship | Some | ||
| Ondansetron (Alphapharm) 4 mg/2 mL injection, 5 x 2 mL ampoules | has TP | Ondansetron (Alphapharm) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR